Aescusan 20 (aescin)

Aescusan 20 (aescin) Medicine

Contraindications

Hypersensitivity.

Pharmaceutical form

Tablets are red-brown in color.

Undesirable effects

In rare cases — dyspeptic phenomena, possible-allergic reactions.

Therapeutic indications

Chronic venous insufficiency of various origins (edema, cramps of the calf muscles, itching, pain and a feeling of heaviness in the legs), varicose veins (including during pregnancy) and post-thrombophlebitis syndrome, lower leg ulcers, inflammatory or postoperative soft tissue edema.

Pharmacotherapeutic group

  • Angioprotectors and microcirculation correctors

Special precautions for storage

In a dry place, at a temperature not exceeding 25 °C.

Keep out of reach of children.

The shelf life of the drug Naphazoline® 203 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Coated tablets 1 table.
dry extract from the fruit of the horse chestnut (Aesculus hippocastanum L.) 250 mg
which corresponds to 20 mg of triterpene glycosides in terms of anhydrous escin  
excipients: magnesium stearate, dimethicone 200, methylhydroxypropylcellulose, polyoxyl-40-stearate, titanium dioxide, polyethylene glycol-35000, MCC, silicon dioxide, water  

in a blister or bottle of 20 pcs., in a box of 2 blisters or bottles.

Nosological classification (ICD-10)

  • I83 Varicose veins of the lower extremities
  • I87. 0 Post-phlebitic syndrome
  • I87. 2 Venous insufficiency (chronic) (peripheral)
  • I89. 0 Lymphatic oedema, not classified elsewhere
  • L98. 4. 2* Trophic skin ulcer
  • R60. 0 Localized edema
  • Z100* CLASS XXII Surgical Practice

Dosage (Posology) and method of administration

Inside, after meals, with the necessary amount of liquid, 1-2 tablets. 3 times a day. The course is 3 months (if necessary, longer after consultation with a doctor).

ATC - Anatomical and therapeutic chemical classification

C05CX Drugs that reduce capillary permeability, other